Published in J Infect Chemother on October 23, 2012
Influenza B-induced refractory cardiogenic shock: a case report. BMC Infect Dis (2013) 0.82
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –. Circ J (2012) 3.70
Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke (2005) 2.56
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma. Blood (2010) 2.00
Evaluation of the impact of atrial fibrillation on rehospitalization events in heart failure patients in recent years. J Cardiol (2012) 2.00
A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. Circ J (2010) 1.79
Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol (2004) 1.57
Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. J Am Coll Cardiol (2008) 1.52
Hemodialysis is an independent predictor of coronary in-stent restenosis after paclitaxel eluting stent implantation. Intern Med (2010) 1.46
Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients. Circ J (2011) 1.45
Two cases of Brugada syndrome associated with spontaneous clinical episodes of coronary vasospasm. Intern Med (2006) 1.45
Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace (2012) 1.45
Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study). Int Heart J (2015) 1.42
Effect of hypothermia therapy after outpatient cardiac arrest due to ventricular fibrillation. Circ J (2009) 1.41
Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarction. Circ J (2012) 1.40
Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure - A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Circ J (2016) 1.40
Cardiomyocyte-derived mitochondrial superoxide causes myocardial electrical remodeling by downregulating potassium channels and related molecules. Circ J (2014) 1.39
Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study). Cardiovasc Drugs Ther (2011) 1.37
Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke (2002) 1.35
Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J (2008) 1.27
Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation (2009) 1.16
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol (2010) 1.07
Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail (2002) 1.07
Myocarditis Associated with Influenza A H1N1pdm2009. Influenza Res Treat (2012) 1.05
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia. Lipids Health Dis (2009) 0.97
Primary cardiac osteosarcoma in a young man with severe congestive heart failure. Intern Med (2007) 0.96
Phase III clinical pharmacology study of tolvaptan. Cardiovasc Drugs Ther (2011) 0.96
Efficacy and safety of tolvaptan in heart failure patients with volume overload. Circ J (2014) 0.96
MRI is useful for diagnosis of H1N1 fulminant myocarditis. Circ J (2010) 0.94
Clinical significance of corticosteroid therapy for eosinophilic myocarditis. Int Heart J (2011) 0.94
The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia. J Atheroscler Thromb (2006) 0.93
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines. Invest New Drugs (2007) 0.93
Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy. Heart Vessels (2013) 0.93
Retropharyngeal abscess due to methicillin-resistant Staphylococcus aureus in a case of acute myeloid leukemia. Intern Med (2005) 0.92
Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med (2003) 0.92
Vasospasms of the radial artery after the transradial approach for coronary angiography and angioplasty. Jpn Heart J (2004) 0.91
Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J (2009) 0.91
Resveratrol ameliorates experimental autoimmune myocarditis. Circ J (2007) 0.90
Angiotensin II receptor antagonist attenuates expression of aging markers in diabetic mouse heart. Circ J (2006) 0.89
C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels (2003) 0.89
No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene. Mol Genet Metab (2012) 0.89
Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Cardiovasc Drugs Ther (2011) 0.89
The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases. J Biol Chem (2013) 0.89
Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy. Heart Vessels (2013) 0.88
Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction. J Artif Organs (2013) 0.88
Is B-type natriuretic peptide-guided heart failure management cost-effective? Int J Cardiol (2004) 0.87
Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J (2003) 0.87
FDG-PET/CT of polymyalgia rheumatica. Mod Rheumatol (2010) 0.86
Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab). Circ J (2004) 0.85
Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation. Diabetes Care (2010) 0.85
Inhomogenic effect of bepridil on atrial electrical remodeling in a canine rapid atrial stimulation model. Circ J (2008) 0.85
Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy. Am J Physiol Heart Circ Physiol (2007) 0.85
Progression of ventricular remodeling and arrhythmia in the primary hyperoxidative state of glutathione-depleted rats. Circ J (2011) 0.84
Arrhythmogenic difference between the left and right atria during rapid atrial activation in a canine model of atrial fibrillation. Circ J (2007) 0.84
Effects of phase II cardiac rehabilitation on job stress and health-related quality of life after return to work in middle-aged patients with acute myocardial infarction. Int Heart J (2009) 0.84
Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network. Eur J Heart Fail (2009) 0.84
Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension. Circ J (2005) 0.83
Rapamycin ameliorates experimental autoimmune myocarditis. Int Heart J (2005) 0.83
Increased serum bilirubin levels coincident with heart failure decompensation indicate the need for intravenous inotropic agents. Int Heart J (2007) 0.83
Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy. Obesity (Silver Spring) (2008) 0.83
Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Br J Pharmacol (2003) 0.83
Verapamil suppresses the inhomogeneity of electrical remodeling in a canine long-term rapid atrial stimulation model. Pacing Clin Electrophysiol (2003) 0.83
Cyclic GMP production by ANP, BNP, and NO during worsening and improvement of chronic heart failure. Jpn Heart J (2003) 0.83
Markedly increased intracellular lipid droplets and disruption of intercellular junctions in biopsied myocardium from a patient with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels (2008) 0.82
Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. J Clin Invest (2015) 0.82
Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure. Circ J (2008) 0.81
Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AF. J Stroke Cerebrovasc Dis (2013) 0.81
Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus. Cardiovasc Ther (2011) 0.81
Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc Res (2004) 0.81
99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging (2002) 0.81
Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome. Curr Vasc Pharmacol (2008) 0.81
CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21). Leuk Res (2013) 0.81
Prognostic significance of right ventricular dimension on acute decompensation in chronic left-sided heart failure. Int Heart J (2011) 0.81
Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis. Circ J (2002) 0.81
Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study. Int J Cardiol (2012) 0.81
[Acute promyelocytic leukemia accompanied by retinoic acid syndrome with complications of acute myocardial infarction and cerebral infarction during treatment with all-trans retinoic acid]. Rinsho Ketsueki (2002) 0.81
Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging. Eur J Nucl Med Mol Imaging (2009) 0.81
Validation of eight genetic risk factors in East Asian populations replicated the association of BRAP with coronary artery disease. J Hum Genet (2009) 0.81
Nanotransportation system for cholera toxin in Vibrio cholerae 01. Med Mol Morphol (2009) 0.81
A new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori. Med Mol Morphol (2014) 0.81
Usefulness of a simple prognostication score in prediction of the prognoses of patients with out-of-hospital cardiac arrests. Int Heart J (2013) 0.81